The cost effectiveness of intralesional steroid therapy for keloids

Dermatologic Surgery

Volumn 36, Issue 10, 2010, Pages 1624-1626

  Anthony, Edwin T ^a,b   Lemonas, Pambos ^b   Navsaria, Harshad A ^a   Moir, Graeme C ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TRIAMCINOLONE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; KELOID; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY; UNITED KINGDOM;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; EAR, EXTERNAL; FACE; GLUCOCORTICOIDS; HEAD; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; LONDON; RECURRENCE; TREATMENT OUTCOME; TRIAMCINOLONE; YOUNG ADULT;

EID: 77957322682     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01696.x     Document Type: Article

References (4)

1. Davies K, Nduka C, Moir G. Nurse-led management of hypertrophic and keloid scars. Nurs Times 2004 100 : 40 4.
2. Thomas JR, Ehlert TK. Scar revision and camouflage. Otolaryngol Clin North Am 1990 23 : 963 73.
3. Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 2006 40 : 111 6.
4. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg 1977 11 : 169 72. (Pubitemid 8289059)